Clinical Trials

Rare diseases aren’t the only field that can benefit from repurposing – the eye is also often overlooked.

New data protection regulations are coming.

Researchers develop a new way to tackle pain: inhibition of RNA-protein interactions.

A review of FDA data suggests that women are now better represented in clinical trials.

Publishing negative results might not flatter – but it does matter.

Outsourcing partnerships aim to reduce costs and improve efficiencies, but don't overlook the human elements!

A half-century-old “bet hedging” hypothesis explains the effectiveness of many drug combinations.

We need to face drug attrition to reduce the early-stage risk of drug development.

Are pharma companies willling to open up and share their clinical trial data?

Looking back on wise words from a year of Sitting Down With interviews.